These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10052754)

  • 1. 9-nitrocamptothecin selectively inhibits human immunodeficiency virus type 1 replication in freshly infected parental but not 9-nitrocamptothecin-resistant U937 monocytoid cells.
    Sadaie MR; Doniger J; Hung CL; Pantazis P
    AIDS Res Hum Retroviruses; 1999 Feb; 15(3):239-45. PubMed ID: 10052754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 9-Nitrocamptothecin inhibits tumor recrosis factor-mediated activation of human immunodeficiency virus type 1 and enhances apoptosis in a latently infected T cell clone.
    Moulton S; Pantazis P; Epstein JS; Sadaie MR
    AIDS Res Hum Retroviruses; 1998 Jan; 14(1):39-49. PubMed ID: 9453250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 9-Nitrocamptothecin inhibits HIV-1 replication in human peripheral blood lymphocytes: a potential alternative for HIV-infection/AIDS therapy.
    Hung CL; Doniger J; Palini A; Snyder SW; Radonovich MF; Brady JN; Pantazis P; Sadaie MR
    J Med Virol; 2001 Jul; 64(3):238-44. PubMed ID: 11424110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Camptothecin and 9-nitrocamptothecin (9NC) as anti-cancer, anti-HIV and cell-differentiation agents. Development of resistance, enhancement of 9NC-induced activities and combination treatments in cell and animal models.
    Pantazis P; Han Z; Balan K; Wang Y; Wyche JH
    Anticancer Res; 2003; 23(5A):3623-38. PubMed ID: 14666658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquisition of cellular resistance to 9-nitro-camptothecin correlates with suppression of transcription factor NF-kappa B activation and potentiation of cytotoxicity by tumor necrosis factor in human histiocytic lymphoma U-937 cells.
    Singh S; Raju U; Mendoza J; Pantazis P; Aggarwal BB
    Anticancer Drugs; 1998 Sep; 9(8):703-14. PubMed ID: 9823429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent inhibition of HIV type 1 replication by an antiinflammatory alkaloid, cepharanthine, in chronically infected monocytic cells.
    Okamoto M; Ono M; Baba M
    AIDS Res Hum Retroviruses; 1998 Sep; 14(14):1239-45. PubMed ID: 9764907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human immunodeficiency virus type 1 replication by a bioavailable serine/threonine kinase inhibitor, fasudil hydrochloride.
    Sato T; Asamitsu K; Yang JP; Takahashi N; Tetsuka T; Yoneyama A; Kanagawa A; Okamoto T
    AIDS Res Hum Retroviruses; 1998 Mar; 14(4):293-8. PubMed ID: 9519889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short).
    Chatterjee D; Schmitz I; Krueger A; Yeung K; Kirchhoff S; Krammer PH; Peter ME; Wyche JH; Pantazis P
    Cancer Res; 2001 Oct; 61(19):7148-54. PubMed ID: 11585748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of 9-nitrocamptothecin-triggered apoptosis in DU-145 human prostate cancer cells by ectopic expression of 14-3-3zeta.
    Chatterjee D; Goldman M; Braastad CD; Darnowski J; Wyche JH; Pantazis P; Goodglick L
    Int J Oncol; 2004 Aug; 25(2):503-9. PubMed ID: 15254750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial characterization of human leukemia U-937 cell sublines resistant to 9-nitrocamptothecin.
    Pantazis P; Mendoza JT; DeJesus A; Rubin E; Kufe D; Giovanella BC
    Eur J Haematol; 1994 Sep; 53(3):135-44. PubMed ID: 7925856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
    Lapenta C; Santini SM; Proietti E; Rizza P; Logozzi M; Spada M; Parlato S; Fais S; Pitha PM; Belardelli F
    Virology; 1999 Oct; 263(1):78-88. PubMed ID: 10544084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic efficacy of 9-nitrocamptothecin in the treatment of human malignant melanoma cells in vitro.
    Pantazis P; Early JA; Mendoza JT; DeJesus AR; Giovanella BC
    Cancer Res; 1994 Feb; 54(3):771-6. PubMed ID: 8306340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of senescent cell-derived inhibitor of DNA synthesis gene, SDI1, in hepatoblastoma (HepG2) cells arrested in the G2-phase of the cell cycle by 9-nitrocamptothecin.
    Khaoustov VI; Ozer A; Smith JR; Noda A; Mearns M; Krishnan B; Slagle BL; Yoffe B
    Lab Invest; 1995 Jul; 73(1):118-27. PubMed ID: 7603034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of glutathione levels by phase II enzyme inducers: lack of inhibition of human immunodeficiency virus type 1 replication in chronically infected monocytoid cells.
    Prochaska HJ; Rubinson L; Yeh Y; Baron P; Polsky B
    Mol Pharmacol; 1994 May; 45(5):916-21. PubMed ID: 8190108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human immunodeficiency virus type 1 replication by blocking IkappaB kinase with noraristeromycin.
    Asamitsu K; Yamaguchi T; Nakata K; Hibi Y; Victoriano AF; Imai K; Onozaki K; Kitade Y; Okamoto T
    J Biochem; 2008 Nov; 144(5):581-9. PubMed ID: 18713798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone inhibits HIV-1 replication in human trophoblast cells through inhibition of autocrine tumor necrosis factor secretion.
    Muñoz LD; Serramía MJ; Fresno M; Muñoz-Fernández MA
    J Infect Dis; 2007 May; 195(9):1294-302. PubMed ID: 17396998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propionate and butyrate esters of camptothecin and 9-nitrocamptothecin as antileukemia prodrugs in vitro.
    Han Z; Cao Z; Chatterjee D; Wyche J; Pantazis P
    Eur J Haematol; 1999 Apr; 62(4):246-55. PubMed ID: 10227458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-alpha-induced HIV-1 replication in latently infected OM10.1 and Ach2 cells.
    Traber KE; Okamoto H; Kurono C; Baba M; Saliou C; Soji T; Packer L; Okamoto T
    Int Immunol; 1999 Feb; 11(2):143-50. PubMed ID: 10069412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel approach to develop anti-HIV drugs: adapting non-nucleoside anticancer chemotherapeutics.
    Sadaie MR; Mayner R; Doniger J
    Antiviral Res; 2004 Jan; 61(1):1-18. PubMed ID: 14670589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular high mobility group box-1 inhibits R5 and X4 HIV-1 strains replication in mononuclear phagocytes without induction of chemokines and cytokines.
    Cassetta L; Fortunato O; Adduce L; Rizzi C; Hering J; Rovere-Querini P; Bianchi ME; Alfano M; Poli G
    AIDS; 2009 Mar; 23(5):567-77. PubMed ID: 19194273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.